Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2007

01-10-2007 | Original Article

Physician Beliefs Regarding Effectiveness of Tobacco Dependence Treatments: Results from the NJ Health Care Provider Tobacco Survey

Authors: Michael B. Steinberg, MD, MPH, Cristine D. Delnevo, PhD, MPH

Published in: Journal of General Internal Medicine | Issue 10/2007

Login to get access

Abstract

Background

Physicians play an increasing role in tobacco dependence treatment as more prescription medications and community resources are developed. Beliefs about effectiveness can influence physicians’ recommendations regarding treatment, so it is critical that these beliefs are evidence-based.

Objective

Describe physicians’ beliefs regarding effectiveness of tobacco treatments.

Design

Self-reported, cross-sectional, mailed survey.

Participants

336 primary care physicians in New Jersey (60.3% response).

Measurements

Demographics, previous tobacco dependence training, awareness of guidelines, and perceived effectiveness of treatments.

Results

Physicians believed combination medications and bupropion to be the most effective (89 and 88% reported somewhat or very effective, respectively) and nicotine nasal spray least effective (50%). For nonpharmacologic treatments, physicians believed behavioral counseling (69%) and programs including group treatment (67%) were most effective, whereas telephone counseling (25%) and internet-based treatment (23%) were the least. Female and non-U.S.-trained physicians generally believed treatments to be more effective.

Conclusions

Physicians in this sample believed that most cessation medications available and behavioral and group-based counseling are effective, which is supported by current evidence in the field. Low perceived effectiveness of telephone and internet treatments could hinder their utilization. Perceived effectiveness may affect physician recommendations. Therefore, training efforts to influence these beliefs warrant further attention.
Literature
1.
go back to reference Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2000. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2000.
2.
go back to reference Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA. 1998;279:604–8.PubMedCrossRef Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA. 1998;279:604–8.PubMedCrossRef
3.
go back to reference Coleman T, Wynn A, Barrett S, Wilson A. Discussion of NRT and other antismoking interventions in UK general practitioners’ routine consultations. Nicotine Tob Res. 2003;5:163–8.PubMedCrossRef Coleman T, Wynn A, Barrett S, Wilson A. Discussion of NRT and other antismoking interventions in UK general practitioners’ routine consultations. Nicotine Tob Res. 2003;5:163–8.PubMedCrossRef
4.
go back to reference Solberg LI, Asche SE, Boyle RG, Boucher JL, Pronk NP. Frequency of physician-directed assistance for smoking cessation in patients receiving cessation medications. Arch Intern Med. 2005;165(6):656–60.PubMedCrossRef Solberg LI, Asche SE, Boyle RG, Boucher JL, Pronk NP. Frequency of physician-directed assistance for smoking cessation in patients receiving cessation medications. Arch Intern Med. 2005;165(6):656–60.PubMedCrossRef
5.
go back to reference Steinberg MB, Akincigil A, Delnevo CD, Crystal S, Carson JL. Gender and age disparities for tobacco dependence treatment: results of the 2001–2002 National Ambulatory Medical Care Survey. Am J Prev Med. 2006;30:405–12.PubMedCrossRef Steinberg MB, Akincigil A, Delnevo CD, Crystal S, Carson JL. Gender and age disparities for tobacco dependence treatment: results of the 2001–2002 National Ambulatory Medical Care Survey. Am J Prev Med. 2006;30:405–12.PubMedCrossRef
6.
go back to reference Goldstein MG, DePue JD, Monroe AD, et al. A population-based survey of physician smoking cessation counseling practices. Prev Med. 1998;27:720–9.PubMedCrossRef Goldstein MG, DePue JD, Monroe AD, et al. A population-based survey of physician smoking cessation counseling practices. Prev Med. 1998;27:720–9.PubMedCrossRef
7.
go back to reference McEwen A, West R, Owen L. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales. Addiction. 2004;99:1470–4.PubMedCrossRef McEwen A, West R, Owen L. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales. Addiction. 2004;99:1470–4.PubMedCrossRef
8.
go back to reference Vogt F, Hall S, Marteau TM. General practitioners beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies. BMC Public Health. 2006;6:277.PubMedCrossRef Vogt F, Hall S, Marteau TM. General practitioners beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies. BMC Public Health. 2006;6:277.PubMedCrossRef
9.
go back to reference McEwen A, Akotia N, West R. General practitioners’ views on the English national smoking cessation guidelines. Addiction. 2001;96(7):997–00.PubMedCrossRef McEwen A, Akotia N, West R. General practitioners’ views on the English national smoking cessation guidelines. Addiction. 2001;96(7):997–00.PubMedCrossRef
10.
go back to reference Delnevo CD, Abatemarco DJ, Steinberg MB. Physicians response rates to a mail survey by specialty and timing of incentive. Am J Prev Med. 2004;26(3):234–36.PubMedCrossRef Delnevo CD, Abatemarco DJ, Steinberg MB. Physicians response rates to a mail survey by specialty and timing of incentive. Am J Prev Med. 2004;26(3):234–36.PubMedCrossRef
11.
go back to reference Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000146. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000146.
12.
go back to reference Croghan IT, Hurt RD, Dakhil SR, et al. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc. 2007;82(2):186–95.PubMedCrossRef Croghan IT, Hurt RD, Dakhil SR, et al. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc. 2007;82(2):186–95.PubMedCrossRef
13.
go back to reference Hays JT, Hurt RD, Rigotti NA, et.al. Sustained release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial. Ann Int Med. 2001;135(6):423–33.PubMed Hays JT, Hurt RD, Rigotti NA, et.al. Sustained release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial. Ann Int Med. 2001;135(6):423–33.PubMed
14.
go back to reference Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New Engl J Med. 1999;340(9):685–91.PubMedCrossRef Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New Engl J Med. 1999;340(9):685–91.PubMedCrossRef
15.
go back to reference Steinberg MB, Foulds J, Richardson DL, Burke MV, Shah P. Pharmacotherapy and smoking cessation at a tobacco dependence clinic. Prev Med. 2006;42(2):114–9.PubMedCrossRef Steinberg MB, Foulds J, Richardson DL, Burke MV, Shah P. Pharmacotherapy and smoking cessation at a tobacco dependence clinic. Prev Med. 2006;42(2):114–9.PubMedCrossRef
16.
go back to reference Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005:(2):CD001292. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005:(2):CD001292.
17.
go back to reference Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001007. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001007.
18.
go back to reference Centers for Disease Control and Prevention. Quickstats: assistance used to quit smoking by adults aged >18 years during the preceding 2 years by type—National Health Interview Survey–United States, 2005. Morb Mort Wkly Rep. 2007;56(20):507. Centers for Disease Control and Prevention. Quickstats: assistance used to quit smoking by adults aged >18 years during the preceding 2 years by type—National Health Interview Survey–United States, 2005. Morb Mort Wkly Rep. 2007;56(20):507.
19.
go back to reference Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006;3:CD002850.PubMed Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006;3:CD002850.PubMed
20.
go back to reference Zhu SH, Anderson CM, Tedeschi GJ, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. New Engl J Med. 2002;347(14):1087–93.PubMedCrossRef Zhu SH, Anderson CM, Tedeschi GJ, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. New Engl J Med. 2002;347(14):1087–93.PubMedCrossRef
21.
go back to reference Swartz LH, Noell JW, Schroeder SW, Ary DV. A randomised control study of a fully automated internet based smoking cessation programme. Tob Control. 2006;15(1):7–12.PubMedCrossRef Swartz LH, Noell JW, Schroeder SW, Ary DV. A randomised control study of a fully automated internet based smoking cessation programme. Tob Control. 2006;15(1):7–12.PubMedCrossRef
22.
go back to reference Walters ST, Wright JA, Shegog R. A review of computer and internet–based interventions for smoking behavior. Addict Behav. 2006;31(2):264–77.PubMedCrossRef Walters ST, Wright JA, Shegog R. A review of computer and internet–based interventions for smoking behavior. Addict Behav. 2006;31(2):264–77.PubMedCrossRef
23.
go back to reference Maheux B, Haley N, Rivard M, Gervais A. Do women physicians do more STD prevention than men? Can Fam Physician. 1997;43:1089–95.PubMed Maheux B, Haley N, Rivard M, Gervais A. Do women physicians do more STD prevention than men? Can Fam Physician. 1997;43:1089–95.PubMed
24.
go back to reference Frank E, Harvey LK. Prevention advice rates of women and men physicians. Arch Fam Med. 1996;5:215–9.PubMedCrossRef Frank E, Harvey LK. Prevention advice rates of women and men physicians. Arch Fam Med. 1996;5:215–9.PubMedCrossRef
25.
go back to reference Delnevo CD, Steinberg MB, Abatemarco DJ, Hausman AJ. Correlates of clinical preventive practices among internal medicine residents. Prev Med. 2003;36(6):645–51.PubMedCrossRef Delnevo CD, Steinberg MB, Abatemarco DJ, Hausman AJ. Correlates of clinical preventive practices among internal medicine residents. Prev Med. 2003;36(6):645–51.PubMedCrossRef
Metadata
Title
Physician Beliefs Regarding Effectiveness of Tobacco Dependence Treatments: Results from the NJ Health Care Provider Tobacco Survey
Authors
Michael B. Steinberg, MD, MPH
Cristine D. Delnevo, PhD, MPH
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 10/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0282-5

Other articles of this Issue 10/2007

Journal of General Internal Medicine 10/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine